May 2003
Volume 44, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2003
Effect of Laser Photocoagulation Treatment for Diabetic Retinopathy on Patients’ Health-related Quality of Life
Author Affiliations & Notes
  • P. Tranos
    Ophthalmology, Royal Free Hospital, London, United Kingdom
  • F. Topouzis
    Ophthalmology, AHEPA General Hospital, Thessaloniki, Greece
  • H. Al Hakim
    Ophthalmology, AHEPA General Hospital, Thessaloniki, Greece
  • M. Harris
    Ophthalmology, AHEPA General Hospital, Thessaloniki, Greece
  • S. Dimitrakos
    Ophthalmology, AHEPA General Hospital, Thessaloniki, Greece
  • P. Economidis
    Ophthalmology, AHEPA General Hospital, Thessaloniki, Greece
  • N. Stangos
    Ophthalmology, AHEPA General Hospital, Thessaloniki, Greece
  • Footnotes
    Commercial Relationships  P. Tranos, None; F. Topouzis, None; H. Al Hakim, None; M. Harris, None; S. Dimitrakos, None; P. Economidis, None; N. Stangos, None.
Investigative Ophthalmology & Visual Science May 2003, Vol.44, 3955. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      P. Tranos, F. Topouzis, H. Al Hakim, M. Harris, S. Dimitrakos, P. Economidis, N. Stangos; Effect of Laser Photocoagulation Treatment for Diabetic Retinopathy on Patients’ Health-related Quality of Life . Invest. Ophthalmol. Vis. Sci. 2003;44(13):3955.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To evaluate the effect of laser photocoagulation for diabetic macular edema (DME) and proliferative diabetic retinopathy (PDR) on patients’ Health Related Quality Of Life (HR-QOL). Methods: The study cohort was composed of 74 subjects with mean age of 63±11 years. 55 of those individuals underwent laser treatment for DME and 19 received panretinal photocoagulation for PDR. Eligible patients with no history of previous laser photocoagulation self-administered the 51-item field-test version of the National Eye Institute Visual Function Questionnaire (NEI-VFQ) and the Medical Outcomes Study 36-item Short Form (SF-36) prior to treatment and 3 months following the last session of laser application. Multi-item scales rating different aspects of QOL were compared prior and after photocoagulation. Age matched individuals with DR who did not require laser treatment were enrolled in a reference sample. Results: Laser photocoagulation for diabetic retinopathy resulted in significant (p<.01) improvement of NEI-VFQ subscale scores associated with general vision (p=.004), near vision (p=.01), distance vision (p<.001), visual expectations (p=.005) and vision specific social functioning and mental health (p=.005 and p<.001 respectively). Of the SF-36 subscales only physical functioning and mental health showed significant improvement (p=.006 and p=.01 respectively). In contrast there was no association between change in composite scores and change in near or distance visual acuity after laser treatment. Conclusions: Photocoagulation for diabetic retinopathy has beneficial effect on patients’ health related quality of life. The use of vision-targeted health status questionnaires in conjunction with the clinical examination appears to provide more comprehensive overview of individuals’ daily well being following laser treatment.

Keywords: quality of life • diabetic retinopathy • clinical (human) or epidemiologic studies: out 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×